poisar

Stocks · News reference

Zymeworks Announces $200 Million Share Repurchase Authorization

Fiscal.ai

Zymeworks Inc. has authorized a second 2026 share repurchase program, allowing for the buyback of up to $200 million of its common stock through 2028.

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
fiscal.ai
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. SEC EDGARSEC EDGAR

    8-K filing — Zymeworks Inc. (ZYME)

    Filed: 2026-11-16 AccNo: 0001937653-26-000070 Size: 197 KB Item 7.01: Regulation FD Disclosure Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits